Literature DB >> 30376428

Circulating Tumor DNA-Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies.

Arvind Dasari1, Axel Grothey1, Scott Kopetz1.   

Abstract

Entities:  

Year:  2018        PMID： 30376428      PMCID： PMC6286158          DOI： 10.1200/JCO.2018.78.9032

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  34 in total

1.  Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  David S Ettinger; Douglas E Wood; Dara L Aisner; Wallace Akerley; Jessica Bauman; Lucian R Chirieac; Thomas A D'Amico; Malcolm M DeCamp; Thomas J Dilling; Michael Dobelbower; Robert C Doebele; Ramaswamy Govindan; Matthew A Gubens; Mark Hennon; Leora Horn; Ritsuko Komaki; Rudy P Lackner; Michael Lanuti; Ticiana A Leal; Leah J Leisch; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Karen Reckamp; Gregory J Riely; Steven E Schild; Theresa A Shapiro; James Stevenson; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2017-04       Impact factor: 11.908

Review 2.  Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies.

Authors:  Alfredo Berruti; Vito Amoroso; Fabio Gallo; Valentina Bertaglia; Edda Simoncini; Rebecca Pedersini; Laura Ferrari; Alberto Bottini; Paolo Bruzzi; Maria Pia Sormani
Journal:  J Clin Oncol       Date:  2014-10-27       Impact factor: 44.544

3.  Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Al B Benson; Alan P Venook; Lynette Cederquist; Emily Chan; Yi-Jen Chen; Harry S Cooper; Dustin Deming; Paul F Engstrom; Peter C Enzinger; Alessandro Fichera; Jean L Grem; Axel Grothey; Howard S Hochster; Sarah Hoffe; Steven Hunt; Ahmed Kamel; Natalie Kirilcuk; Smitha Krishnamurthi; Wells A Messersmith; Mary F Mulcahy; James D Murphy; Steven Nurkin; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; Constantinos T Sofocleous; Elena M Stoffel; Eden Stotsky-Himelfarb; Christopher G Willett; Christina S Wu; Kristina M Gregory; Deborah Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2017-03       Impact factor: 11.908

4.  Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.

Authors:  Aimery de Gramont; Eric Van Cutsem; Hans-Joachim Schmoll; Josep Tabernero; Stephen Clarke; Malcolm J Moore; David Cunningham; Thomas H Cartwright; J Randolph Hecht; Fernando Rivera; Seock-Ah Im; György Bodoky; Ramon Salazar; Frédérique Maindrault-Goebel; Einat Shacham-Shmueli; Emilio Bajetta; Martina Makrutzki; Aijing Shang; Thierry André; Paulo M Hoff
Journal:  Lancet Oncol       Date:  2012-11-16       Impact factor: 41.316

Review 5.  Liquid biopsies come of age: towards implementation of circulating tumour DNA.

Authors:  Jonathan C M Wan; Charles Massie; Javier Garcia-Corbacho; Florent Mouliere; James D Brenton; Carlos Caldas; Simon Pacey; Richard Baird; Nitzan Rosenfeld
Journal:  Nat Rev Cancer       Date:  2017-02-24       Impact factor: 60.716

6.  Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.

Authors:  Leonard B Saltz; Donna Niedzwiecki; Donna Hollis; Richard M Goldberg; Alexander Hantel; James P Thomas; Anthony L A Fields; Robert J Mayer
Journal:  J Clin Oncol       Date:  2007-08-10       Impact factor: 44.544

7.  Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.

Authors:  Jeanne Tie; Yuxuan Wang; Cristian Tomasetti; Lu Li; Simeon Springer; Isaac Kinde; Natalie Silliman; Mark Tacey; Hui-Li Wong; Michael Christie; Suzanne Kosmider; Iain Skinner; Rachel Wong; Malcolm Steel; Ben Tran; Jayesh Desai; Ian Jones; Andrew Haydon; Theresa Hayes; Tim J Price; Robert L Strausberg; Luis A Diaz; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Peter Gibbs
Journal:  Sci Transl Med       Date:  2016-07-06       Impact factor: 17.956

8.  Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.

Authors:  Jeanne Tie; Joshua D Cohen; Bert Volgestein; Peter Gibbs; Yuxuan Wang; Lu Li; Michael Christie; Koen Simons; Hany Elsaleh; Suzanne Kosmider; Rachel Wong; Desmond Yip; Margaret Lee; Ben Tran; David Rangiah; Matthew Burge; David Goldstein; Madhu Singh; Iain Skinner; Ian Faragher; Matthew Croxford; Carolyn Bampton; Andrew Haydon; Ian T Jones; Christos S Karapetis; Timothy Price; Mary J Schaefer; Jeanne Ptak; Lisa Dobbyn; Natallie Silliman; Isaac Kinde; Cristian Tomasetti; Nickolas Papadopoulos; Kenneth Kinzler
Journal:  Gut       Date:  2018-02-02       Impact factor: 23.059

9.  Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.

Authors:  Gaowei Fan; Kuo Zhang; Xin Yang; Jiansheng Ding; Zujian Wang; Jinming Li
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

10.  An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

Authors:  Aaron M Newman; Scott V Bratman; Jacqueline To; Jacob F Wynne; Neville C W Eclov; Leslie A Modlin; Chih Long Liu; Joel W Neal; Heather A Wakelee; Robert E Merritt; Joseph B Shrager; Billy W Loo; Ash A Alizadeh; Maximilian Diehn
Journal:  Nat Med       Date:  2014-04-06       Impact factor: 53.440
View more
  10 in total

1.  Preoperative serum ctDNA predicts early hepatocellular carcinoma recurrence and response to systemic therapies.

Authors:  Yizhen Fu; Zhenyun Yang; Zili Hu; Zhoutian Yang; Yangxun Pan; Jinbin Chen; Juncheng Wang; Dandan Hu; Zhongguo Zhou; Li Xu; Minshan Chen; Yaojun Zhang
Journal:  Hepatol Int       Date:  2022-06-08       Impact factor: 9.029

Review 2.  The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer.

Authors:  Alisha Bent; Shreya Raghavan; Arvind Dasari; Scott Kopetz
Journal:  Clin Colorectal Cancer       Date:  2022-03-26       Impact factor: 4.035

3.  Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers.

Authors:  Laura E Fischer; Sebastian Stintzing; Volker Heinemann; Ulrich Keilholz; Dietmar Keune; Claudia Vollbrecht; Thomas Burmeister; Andreas Kind; Lena Weiss; David Horst; Thomas Kirchner; Frederick Klauschen; Andreas Jung; Christoph Benedikt Westphalen; Ivan Jelas
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

Review 4.  Circulating tumor DNA in colorectal cancer: opportunities and challenges.

Authors:  Feifei Bi; Qiwei Wang; Qian Dong; Yuanhe Wang; Liqun Zhang; Jingdong Zhang
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

5.  Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.

Authors:  Aparna R Parikh; Emily E Van Seventer; Giulia Siravegna; Anna V Hartwig; Ariel Jaimovich; Yupeng He; Katie Kanter; Madeleine G Fish; Kathryn D Fosbenner; Benchun Miao; Susannah Phillips; John H Carmichael; Nihaarika Sharma; Joy Jarnagin; Islam Baiev; Yojan S Shah; Isobel J Fetter; Heather A Shahzade; Jill N Allen; Lawrence S Blaszkowsky; Jeffrey W Clark; Jon S Dubois; Joseph W Franses; Bruce J Giantonio; Lipika Goyal; Samuel J Klempner; Ryan D Nipp; Eric J Roeland; David P Ryan; Colin D Weekes; Jennifer Y Wo; Theodore S Hong; Liliana Bordeianou; Cristina R Ferrone; Motaz Qadan; Hiroko Kunitake; David Berger; Rocco Ricciardi; James C Cusack; Victoria M Raymond; AmirAli Talasaz; Genevieve M Boland; Ryan B Corcoran
Journal:  Clin Cancer Res       Date:  2021-04-29       Impact factor: 12.531

6.  Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Authors:  J Remon; R García-Campelo; E de Álava; R Vera; J L Rodríguez-Peralto; Á Rodríguez-Lescure; B Bellosillo; P Garrido; F Rojo; R Álvarez-Alegret
Journal:  Clin Transl Oncol       Date:  2019-09-26       Impact factor: 3.405

Review 7.  Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer.

Authors:  Gloria Chan; Cheng E Chee
Journal:  Cancers (Basel)       Date:  2020-11-26       Impact factor: 6.639

Review 8.  Research Progress on Postoperative Minimal/Molecular Residual Disease Detection in Lung Cancer.

Authors:  Manqi Wu; Haifeng Shen; Ziyang Wang; Nnennaya Kanu; Kezhong Chen
Journal:  Chronic Dis Transl Med       Date:  2022-03-31

9.  A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non-small cell lung cancer (JCOG 0707).

Authors:  Hideo Kunitoh; Masahiro Tsuboi; Masashi Wakabayashi; Morihito Okada; Kenji Suzuki; Shun-Ichi Watanabe; Hisao Asamura
Journal:  JTCVS Open       Date:  2020-08-29

10.  Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR, BRAF, and KRAS mutations.

Authors:  Jason C Poole; Shan-Fu Wu; Timothy T Lu; Cecile Rose T Vibat; Anh Pham; Errin Samuelsz; Manisha Patel; Jeffrey Chen; Tony Daher; Veena M Singh; Lyle J Arnold
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.